Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 26, 2024 02:00 ET | Source: Polaris Market Research & Consulting LLP

mRNA Vaccines and Therapeutics Market Expected to Reach USD 253.83 Billion By 2034, With 16.7% CAGR From 2025 to 2034 | PMR

New York, USA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview The market for mRNA vaccines and therapeutics is poised to grow, according to the latest research study by Polaris Market Research....
December 11, 2024 07:01 ET | Source: GEn1E Lifesciences Inc.

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Dr. Nader, current Independent Board Director at Moderna and Senior Advisor at Blackstone Life Sciences, joins GEn1E Lifesciences board as chair.
November 19, 2024 08:00 ET | Source: BioTech Breakthrough

2024 BioTech Breakthrough Awards Program Celebrates Groundbreaking Biotechnology Innovators Around the World

LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
November 18, 2024 12:30 ET | Source: Custom Market Insights

Global Allergy Diagnostics and Therapeutics Market Size/Share Worth USD 78,036.1 Million by 2033 at a 8.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Allergy Diagnostics and Therapeutics Market Size, Trends and Insights By Product...
November 14, 2024 07:30 ET | Source: Tourmaline Bio, Inc.

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
November 12, 2024 07:00 ET | Source: Wugen

Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy, WU-CART-007, in Patients with Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia or T Cell Lymphoblastic Lymphoma

Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy, WU-CART-007
October 31, 2024 07:30 ET | Source: Tourmaline Bio, Inc.

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio to Present at Upcoming Investor Conferences
October 30, 2024 08:01 ET | Source: A Race Against Blindness

A Race Against Blindness Grants $1 Million Supporting Axovia Therapeutics’ Planned Clinical Trial for Bardet-Biedl Syndrome (BBS)

A Race Against Blindness grants $1M to Axovia Therapeutics for a clinical trial targeting blindness and obesity in Bardet-Biedl Syndrome.
October 30, 2024 08:00 ET | Source: A Race Against Blindness

A Family’s Race To Treat Childhood Blindness: A Race Against Blindness Grants $1 Million to Bardet-Biedl Syndrome Research

Arizona Family’s Journey: A Race Against Blindness grants $1M to Bardet-Biedl Syndrome research, fueling hope and potential cures for childhood blindness.
October 15, 2024 07:30 ET | Source: Tourmaline Bio, Inc.

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November